AnaptysBio announced that its CEO, Daniel Faga, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. The company focuses on managing financial collaborations for its drugs Jemperli with GSK and imsidolimab with Vanda, aiming to protect and return royalty value to shareholders. This event provides an opportunity for investors to hear directly from the CEO about the company's strategies and outlook. The fireside chat is scheduled for 1:30pm ET and interested parties can register online.
The U.S. Bankruptcy Court for the Central District of California confirmed the Plan of Liquidation for Oceanwide Plaza LLC, enabling the $470 million sale of the stalled Downtown Los Angeles development to KPC Square, a joint venture between KPC Grou...
Escalating conflict between the U.S. and Iran has kept oil prices elevated, raising concerns about a fresh energy shock that could increase global headline inflation by about 0.8 percentage points, according to BlackRock. Regions like Europe and part...
General Motors will report its second-quarter earnings before the market opens, with analysts expecting adjusted earnings per share of $3.20 and revenue of $47.01 billion. This would represent a 26% increase in earnings per share but a slight 0.2% de...
Bitcoin long-term holders have decreased their selling losses to about 6%, improving from a previous 27% loss, signaling less panic in the market. Despite this, Bitcoin has yet to show strong bullish momentum as rising oil prices and inflation concer...
Bombardier announced that its Global 8000 business jet has received an Environmental Product Declaration (EPD), joining other models like the Challenger 650 and Global 7500. This makes Bombardier the only business jet maker to publicly disclose the f...
